Abiopharma

🔍 BURKE JAMES A (Director)

Company: Vistra Corp. (VST)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock at $135.0 per share (Direct)
  Date: 2026-08-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,139,687.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: H | shares_owned_after: 61,690.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: By the James A. Burke 2012 Irrevocable Trust, dated 12/03/2012 | shares_owned_after: 34,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: By the Marti E. Burke 2012 Irrevocable Trust, dated 10/16/2012 | shares_owned_after: 259.00

Footnotes:

• F1: The number of securities shown to be beneficially owned reflects an adjustment upward by 436,173 shares of common stock due to the transfer of 436,173 shares of common stock that was previously directly owned by Reporting Person.
• F2: The number of securities shown to be beneficially owned reflects an adjustment downward by 436,173 shares of common stock due to the transfer of 436,173 shares of common stock to the JAMEB, LP, a limited partnership jointly owned by the Reporting Person and his spouse.